Description
Description
Tirzepatide (30mg) is a high-purity dual GIP and GLP-1 receptor agonist. This concentration supports large-scale metabolic research projects requiring high-dose incretin receptor activation.
Research Applications
Studies explore the impact of high-dose dual receptor targeting on systemic metabolic regulation.








Reviews
There are no reviews yet.